Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DFTX Definium Therapeutics

Post-Mkt 09-01 19:44:23 EDT

38.50

-1.22

-3.07%

盘后38.63

+0.13+0.34%

19:41 EDT

High40.00	Low38.15	Vol1.57M
Open39.38	D1 Closing39.72	Amplitude4.66%
Mkt Cap5.17B	Tradable Cap5.05B	Total Shares134.37M
T/O60.95M	T/O Rate1.20%	Tradable Shares131.11M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":38.5,"timestamp":1788292800000,"preClose":39.72,"halted":0,"volume":1571966,"hourTrading":{"tag":"盘后","latestPrice":38.63,"preClose":38.5,"latestTime":"19:41 EDT","volume":25916,"amount":998212.4549319999,"timestamp":1788306095234,"change":0.13,"changeRate":0.003377,"amplitude":0.025844},"delay":0,"changeRate":-0.030715005035246698,"floatShares":131114280,"shares":134366950,"eps":-3.482311,"marketStatus":"Post-Mkt","change":-1.22,"latestTime":"09-01 19:44:23 EDT","open":39.38,"high":40,"low":38.15,"amount":60945051.081530005,"amplitude":0.046576,"askPrice":39.42,"askSize":20,"bidPrice":38.47,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":39.72,"preHourTrading":{"tag":"盘前","latestPrice":39.37,"preClose":39.72,"latestTime":"09:29 EDT","volume":5846,"amount":230467.55951999998,"timestamp":1788269399999,"change":-0.35,"changeRate":-0.008812,"amplitude":0.037064},"postHourTrading":{"tag":"盘后","latestPrice":38.63,"preClose":38.5,"latestTime":"19:41 EDT","volume":25916,"amount":998212.4549319999,"timestamp":1788306095234,"change":0.13,"changeRate":0.003377,"amplitude":0.025844},"volumeRatio":0.894838,"impliedVol":1.085,"impliedVolPercentile":0.6752},"requestUrl":"/m/hq/s/DFTX","defaultTab":"news","newsList":[{"id":"2664178888","title":"Definium Therapeutics Grants 88,900 Inducement Stock Options to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2664178888","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664178888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:01","pubTimestamp":1788206496,"startTime":"0","endTime":"0","summary":"Definium Therapeutics grants 88,900 inducement stock options to new hiresDefinium Therapeutics issued inducement stock options for 88,900 common shares to three newly hired non-executive employees.Gra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL1P0HbT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663002865","title":"Definium Therapeutics, Inc. put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002865","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002865?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:15","pubTimestamp":1788189307,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Definium Therapeutics (DFTX), Inc. with 2,903 puts trading, or 6x expected. Most active are Oct-26 37 puts and Oct-26 50 call...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-inc-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-inc-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663700958","title":"Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Definium Therapeutics (DFTX) and IDEAYA Biosciences (IDYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663700958","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663700958?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:50","pubTimestamp":1788184220,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vor Biopharma (VOR), Definium Therapeutics (DFTX) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vor-biopharma-vor-definium-therapeutics-dftx-and-ideaya-biosciences-idya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vor-biopharma-vor-definium-therapeutics-dftx-and-ideaya-biosciences-idya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","BK4581","XBI","VOR","IDYA","BK4137","DFTX","LU0029874061.USD","XLV","LU0128526141.USD","BK4139","BK4585","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663070428","title":"Definium Therapeutics (DFTX) Gets a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2663070428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663070428?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:36","pubTimestamp":1788176219,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Definium Therapeutics today and set a price target of $60.00. Matteis covers the He...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/definium-therapeutics-dftx-gets-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/definium-therapeutics-dftx-gets-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662571336","title":"Definium Therapeutics to Present at TD Cowen Novel Mechanisms in Neuropsychiatry Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2662571336","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662571336?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:05","pubTimestamp":1787742344,"startTime":"0","endTime":"0","summary":"Definium Therapeutics to present at TD Cowen Novel Mechanisms in Neuropsychiatry SummitDefinium Therapeutics schedules a virtual fireside chat on Tuesday, Sept. 1, 2026 at 1:00 p.m. ET.Discussion to c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLnMHt6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4207","MNSH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492449","title":"Definium Therapeutics Posts Strong Phase 3 GAD Data for DT120","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492449","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492449?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:40","pubTimestamp":1787085632,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) has issued an announcement. Definium Therapeutics reported positive topline Phase 3 results from its Voyage study...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-posts-strong-phase-3-gad-data-for-dt120?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-posts-strong-phase-3-gad-data-for-dt120?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492414","title":"Definium Therapeutics Issues Inducement Stock Options to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492414","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492414?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:39","pubTimestamp":1787085575,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) just unveiled an announcement. Definium Therapeutics has granted stock options to two newly hired non‑executive e...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-inducement-stock-options-to-new-hires-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-inducement-stock-options-to-new-hires-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660846586","title":"Definium Therapeutics Initiated at Buy by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2660846586","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660846586?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:17","pubTimestamp":1787044620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660550624","title":"Definium Therapeutics initiated with a Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2660550624","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660550624?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:55","pubTimestamp":1787018108,"startTime":"0","endTime":"0","summary":"BofA analyst Tazeen Ahmad initiated coverage of Definium Therapeutics (DFTX) with a Buy rating and $75 price target The company’s lead asset, DT120...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-initiated-with-a-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-initiated-with-a-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660643426","title":"Definium Therapeutics Issues Inducement Stock Options for 32,900 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2660643426","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660643426?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:01","pubTimestamp":1786996877,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement stock options for 32,900 shares to new hiresDefinium Therapeutics issued inducement stock options covering 32,900 common shares to two newly hired non-executive","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL47wSLg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660488352","title":"Definium Therapeutics price target raised to $66 from $57 at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2660488352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660488352?lang=en_us&edition=fundamental","pubTime":"2026-08-17 15:41","pubTimestamp":1786952513,"startTime":"0","endTime":"0","summary":"RBC Capital raised the firm’s price target on Definium Therapeutics (DFTX) to $66 from $57 and keeps an Outperform rating on the shares. Following ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-66-from-57-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-66-from-57-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129989","title":"Definium Therapeutics Price Target Raised to $55.00/Share from $50.00 by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129989?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:21","pubTimestamp":1786738860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123102","title":"Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Sutro Biopharma (STRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659123102?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:00","pubTimestamp":1786726822,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Su...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definium-therapeutics-dftx-ionis-pharmaceuticals-ions-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definium-therapeutics-dftx-ionis-pharmaceuticals-ions-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","LU0029874061.USD","HCSG","BK4007","XLV","BK4585","XBI","BK4139","LU0128526141.USD","IONS","BK4588","DFTX","BK4137","STRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167311","title":"Definium Therapeutics Publishes Corporate Presentation Outlining DT120 ODT Clinical Development Pipeline in Mental Health Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167311","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167311?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:20","pubTimestamp":1786652405,"startTime":"0","endTime":"0","summary":"Definium Therapeutics publishes corporate presentation outlining DT120 ODT clinical development pipeline in mental health indicationsDefinium outlined a late-stage program for DT120 ODT (lysergide) ta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2pQv6j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659516574","title":"Definium Therapeutics' DT120 Data Boosts Confidence in Future Trials, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2659516574","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659516574?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:44","pubTimestamp":1786635856,"startTime":"0","endTime":"0","summary":"Definium Therapeutics' (DFTX) phase 3 data for DT120 in generalized anxiety disorder looked better than the stock's muted reaction suggests, with the results increasing confidence in future studies an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128525929.USD","BK4207","DFTX","BK4007","LU0029864427.USD","LU1267930573.SGD","LU0708994859.HKD","LU0310800379.SGD","GSIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659415539","title":"RBC Adjusts PT on Definium Therapeutics to $66 From $57, Keeps Outperform Speculative Risk Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2659415539","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659415539?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:40","pubTimestamp":1786617635,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) has an average rating of buy and mean price target of $65.69, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659139535","title":"U.S. Research Roundup-Airbnb, Five Below, Silgan Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2659139535","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659139535?lang=en_us&edition=fundamental","pubTime":"2026-08-13 14:48","pubTimestamp":1786603733,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan HoldingsAug 13 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Airbnb, Fi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4N44A0G6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSCO","CC","AIZ","ABNB","AMWL","CHRD","GASZ","AMTM","ARXS","AKAM","EAT","PKB","AMRZ","ATO","BESF","LNG","ANRO","ARMK","DFTX","ACM","CRGY","DVN","PXI","AX","CBRS","SPRX","CRWV","AOSL","MLPI","CORD","BBY","BGS","AHR","CAH","COHX","CYTK","APGE","APA","ALGM","CSV","COHR","COHC","BTGO","COHH","CRWG","AADX","ACH","AIQ","ANDG","ALL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907385","title":"Sector Update: Healthcare Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907385","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907385?lang=en_us&edition=fundamental","pubTime":"2026-08-13 03:58","pubTimestamp":1786564721,"startTime":"0","endTime":"0","summary":"Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and the State Street Health Care Select Sector SPDR ETF  adding 0.3%.The iShares Biotechnology ETF  rose 0.5%.In corporate news, Merck  shares rose 2.4% after Daiwa upgraded the stock to outperform from neutral and raised its price target to $143 per share from $120.Cencora  said that certain Walgreens volume that was being serviced by the company, separate from the prime vendor agreement, has started moving outside the company from July 1. Meanwhile, Cencora said its prime vendor agreement remains unchanged and accounts for the majority of its business with Walgreens. Cencora shares fell past 5%.Legend Biotech  could see pressures from competition and recent leadership change, potentially weighing on Carvykti myeloma therapy strategy, Oppenheimer said. It downgraded Legend to perform from outperform. Shares fell 5.2%.Definium Therapeutics  shares rose 5% after the firm said its phase 3 trial","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1934455194.USD","BK4550","LU0868494708.USD","LU0320765489.SGD","BK4529","LU2023250504.SGD","FTXH","LU1093756325.SGD","LU2491050154.USD","LU2237957811.SGD","LU1941712264.USD","LU1084165304.USD","LU1291159041.SGD","LU0965509283.SGD","LU1989772923.USD","LU1934455863.HKD","LU0965509101.SGD","BK4084","LU0130102774.USD","PPH","BK4139","IE00BBT3K403.USD","SGXZ23171101.USD","LU1934455277.USD","IE0002141913.USD","LU1941712348.USD","LU1069347547.HKD","LU2357627491.SGD","LU2491050071.SGD","SG9999013999.USD","LU0980610538.SGD","LU1917777945.USD","BK4533","LU0124676726.USD","BK4559","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU2491049909.HKD","LU1057294990.SGD","IYH","SG9999001176.SGD","LU2324357040.USD","FHLC","LU1037948541.HKD","SG9999014567.USD","LU1093756168.USD","LU0238689110.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU0985320562.USD","LU0234572021.USD","RXL","HRTS","BK4505","SG9999002232.USD","LU1989771016.USD","IE000M9KFDE8.USD","IE00B1BXHZ80.USD","LU0289739699.SGD","LU0868494617.USD","LU0203347892.USD","LU1066053197.SGD","LU2125154935.USD","LU0122379950.USD","LU2360032135.SGD","MEMS","IE0009355771.USD","LU1974910355.USD","LU1261432733.SGD","LU0070302665.USD","LU1923622614.USD","LU2433249047.HKD","LU2361044949.HKD","IE00BLSP4239.USD","LU0432979614.USD","LU2125909593.SGD","LU0942090050.USD","LU2361044865.SGD","LU2237957902.USD","BK4585","BK4588","SG9999002224.SGD","XBI","LU0098860793.USD","BK4175","LU1116320901.HKD","BMED","LU0477156953.USD","LU0320765646.SGD","LU0823416689.USD","LU1023059063.AUD","IBB","LU2125154778.USD","LU0211331839.USD","LU0689626769.HKD","LU1162221912.USD","LU2125909247.SGD","VHT","GDOC","IE00BN8TJ469.HKD","COR","LU0648001328.SGD","LU0058720904.USD","MEDI","BK4516","LU1430594728.SGD","LU0861579265.USD","LU1066051811.HKD","JDOC","LU0130517989.USD","IE00BSNM7G36.USD","XLV","LU0208291251.USD","MRK","IE00BFTCPJ56.SGD","LU0965509010.AUD","LU1929549753.HKD","LU2089984988.USD","SG9999014559.SGD","TRUH","LU0203345920.USD","IHE","LU1585245621.USD","IE00BJJMRZ35.SGD","BK4534","SG9999014542.SGD","LU2106854487.HKD","IE00B2B36J28.USD","LU0106261372.USD","BK4581","LU0006306889.USD","LU1061106388.HKD","LU0265550359.USD","SG9999015341.SGD","LU1814569148.SGD","CANC","LU2023250843.SGD","LU2461242641.AUD","PAWZ","IE00BLSP4452.SGD","LU0266013472.USD","LU1035773651.USD","LU1066051498.USD","DFTX","LU1201861249.SGD","LU1119994496.HKD","LABU","LU0265550946.USD","LU0965508806.USD","LU2361045086.USD","LU1066051225.USD","LU1571399168.USD","SG9999001440.SGD","LEGN","LU1116320737.USD","SG9999004303.SGD","SG9999014575.USD","LU1037948897.HKD","LU2112291526.USD","SG9999015358.SGD","IXJ","LU1699723380.USD","LU1983299246.USD","LU0859254822.USD","SG9999001176.USD","LU1989772840.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659902243","title":"Definium Therapeutics Price Target Raised to $66.00/Share from $50.00 by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2659902243","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659902243?lang=en_us&edition=fundamental","pubTime":"2026-08-13 03:25","pubTimestamp":1786562700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659092299","title":"U.S. Stocks on the MOVE-Sutro Biopharma, Humacyte","url":"https://stock-news.laohu8.com/highlight/detail?id=2659092299","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659092299?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:17","pubTimestamp":1786551433,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Sutro Biopharma, HumacyteAugust 12 (Reuters)-Wall Street's main indexes rose on Wednesday, with the Nasdaq outperforming peers as upbeat earnings from AI infrastructure fi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL6N4490YK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","SLNCF","CIEN","OPLN","HRB","SVV","ANNX","SMCI","OFAL","ABSI","CRWV","NCMI","UFO","WXM","LUMA","TAN","LAZR","UAMY","EGGY","EAT","ALT","TECH","NBIS","SMCL","SLXN","LQDA","SMMT","TRMB","O","DPRE","SLN","HUMA","BETA","CAVA","FSLR","STRO","EROC","SMWB","NBIZ","LOCL","CHTR","LITE","GAP","NBIX","CORD","DFTX","NTHI","PFGC","TPL","TSHA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.definiumtx.com;ir.definiumtx.com","stockEarnings":[{"period":"1week","weight":-0.082},{"period":"1month","weight":-0.0873},{"period":"3month","weight":0.7375},{"period":"6month","weight":1.2365},{"period":"1year","weight":3.473},{"period":"ytd","weight":1.9664}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0268},{"period":"3month","weight":0.0098},{"period":"6month","weight":0.1196},{"period":"1year","weight":0.1891},{"period":"ytd","weight":0.1248}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.130491},{"month":2,"riseRate":0.8,"avgChangeRate":0.136845},{"month":3,"riseRate":0.4,"avgChangeRate":0.072082},{"month":4,"riseRate":0.8,"avgChangeRate":0.037703},{"month":5,"riseRate":0.5,"avgChangeRate":0.01554},{"month":6,"riseRate":0.5,"avgChangeRate":0.064762},{"month":7,"riseRate":0.666667,"avgChangeRate":0.160554},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.090843},{"month":9,"riseRate":0.2,"avgChangeRate":-0.174855},{"month":10,"riseRate":0.6,"avgChangeRate":0.009639},{"month":11,"riseRate":0.4,"avgChangeRate":0.026551},{"month":12,"riseRate":0.4,"avgChangeRate":-0.08416}],"exchange":"NASDAQ","name":"Definium Therapeutics","nameEN":"Definium Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Definium Therapeutics,DFTX,Definium Therapeutics股票,Definium Therapeutics股票老虎,Definium Therapeutics股票老虎国际,Definium Therapeutics行情,Definium Therapeutics股票行情,Definium Therapeutics股价,Definium Therapeutics股市,Definium Therapeutics股票价格,Definium Therapeutics股票交易,Definium Therapeutics股票购买,Definium Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}